1) Gruppen LD, Woolliscroft JO, Wolf FM (1988) The contribution of different components of the clinical encounter in generating and eliminating diagnostic hypotheses. Res Med Educ 27:242-247.

CAS  PubMed  Google Scholar 

Srigley JR, Judge M, Helliwell T, Birdsong GG, Ellis DW (2021) The International Collaboration on Cancer Reporting (ICCR): a decade of progress towards global pathology standardisation and data interoperability. Histopathology 79:897–901. https://doi.org/10.1111/his.14431.

Ghossein R, Barletta JA, Bullock M, Johnson SJ, Kakudo K, Lam AK, Moonim MT, Poller DN, Tallini G, Tuttle RM, Xu B, Gill AJ (2021) Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol 110:62–72. https://doi.org/10.1016/j.humpath.2020.08.009.

Williams MD, DeLellis RA, Erickson LA, Gupta R, Johnson SJ, Kameyama K, Natu S, Ng T, Perren A, Perrier ND, Seethala RR, Gill AJ (2021) Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol 110:73–82. https://doi.org/10.1016/j.humpath.2020.07.008.

Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, Volante M, Gill AJ (2021) Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol 110:50–61. https://doi.org/10.1016/j.humpath.2020.10.001.

Thompson LDR, Gill AJ, Asa SL, Clifton-Bligh RJ, de Krijger RR, Kimura N, Komminoth P, Lack EE, Lenders JWM, Lloyd RV, Papathomas TG, Sadow PM, Tischler AS (2021) Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol 110:83–97. https://doi.org/10.1016/j.humpath.2020.04.012.

van Velthuysen MF, Couvelard A, Rindi G, Fazio N, Hörsch D, Nieveen van Dijkum EJ, Klöppel G, Perren A (2022) ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology. J Neuroendocrinol 34:e13100. https://doi.org/10.1111/jne.13100.

Nosé V, Ezzat S, Horvath E, Kovacs K, Laws ER, Lloyd R, Lopes MB, Asa SL (2011) Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med 135:640–6. https://doi.org/10.5858/2010-0470-SAR1.1.

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33:27–63. https://doi.org/10.1007/s12022-022-09707-3.

Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ (2022) Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol 33:64–89. https://doi.org/10.1007/s12022-022-09709-1.

Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG (2022) Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol 33:155–196. https://doi.org/10.1007/s12022-022-09710-8.

Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A (2022) Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol 33:90–114. https://doi.org/10.1007/s12022-022-09704-6.

Cibas ES, Ali SZ (2017) The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 27:1341–1346. https://doi.org/10.1089/thy.2017.0500.

Tomaszewski JE, Bear HD, Connally JA, Epstein JI, Feldman M, Foucar K, Layfield L, LiVolsi V, Sirota RL, Stoler MH, Stombler RE (2000) Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol 114:329–335. https://doi.org/10.1093/ajcp/114.3.329.

Simpson PR, Tschang TP (1993) ADASP recommendations: consultations in surgical pathology. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 24:1382. https://doi.org/10.1016/0046-8177(93)90276-m.

Epstein JI, Walsh PC, Sanfilippo F (1996) Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol 20:851–857. https://doi.org/10.1097/00000478-199607000-00008.

Farooq A, Abdelkader A, Javakhishivili N, Moreno GA, Kuderer P, Polley M, Hunt B, Giorgadze TA, Jorns JM (2021) Assessing the value of second opinion pathology review. Int J Qual Health Care 33:mzab032. https://doi.org/10.1093/intqhc/mzab032.

Duregon E, Volante M, Bollito E, Goia M, Buttigliero C, Zaggia B, Berruti A, Scagliotti GV, Papotti M (2015) Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. Hum Pathol 46:1799–1807. https://doi.org/10.1016/j.humpath.2015.08.012.

Merola E, Zandee W, de Mestier L, Klümpen HJ, Makulik K, Geboes K, van Velthuysen ML, Couvelard A, Cros J, van Eeden S, Hoorens A, Stephenson T, Zajęcki W, de Herder W, Munir A (2021) Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? Neuroendocrinology 111:170–177. https://doi.org/10.1159/000507082.

Swarts DR, van Suylen RJ, den Bakker MA, van Oosterhout MF, Thunnissen FB, Volante M, Dingemans AM, Scheltinga MR, Bootsma GP, Pouwels HM, van den Borne BE, Ramaekers FC, Speel EJ (2014) Interobserver variability for the WHO classification of pulmonary carcinoids. Am J Surg Pathol 38:1429–1436. https://doi.org/10.1097/PAS.0000000000000300.

Cree IA (2022) From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors. Endocr Pathol 33:3–5. https://doi.org/10.1007/s12022-021-09701-1.

La Rosa S (2023) Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future. Endocr Pathol 34:79–97. https://doi.org/10.1007/s12022-023-09755-3.

Luchini C, Pantanowitz L, Adsay V, Asa SL, Antonini P, Girolami I, Veronese N, Nottegar A, Cingarlini S, Landoni L, Brosens LA, Verschuur AV, Mattiolo P, Pea A, Mafficini A, Milella M, Niazi MK, Gurcan MN, Eccher A, Cree IA, Scarpa A (2022) Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. Mod Pathol 35:712–720. https://doi.org/10.1038/s41379-022-01055-1.

Potorac I, Bonneville JF, Daly AF, de Herder W, Fainstein-Day P, Chanson P, Korbonits M, Cordido F, Baranski Lamback E, Abid M, Raverot V, Raverot G, Anda Apiñániz E, Caron P, Du Boullay H, Bildingmaier M, Bolanowski M, Laloi-Michelin M, Borson-Chazot F, Chabre O, Christin-Maitre S, Briet C, Diaz-Soto G, Bonneville F, Castinetti F, Gadelha MR, Oliveira Santana N, Stelmachowska-Banaś M, Gudbjartsson T, Villar-Taibo R, Zornitzki T, Tshibanda L, Petrossians P, Beckers A (2022) Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases. J Clin Endocrinol Metab 107:e3313-e3320. https://doi.org/10.1210/clinem/dgac274.

Akirov A, Asa SL, Larouche V, Mete O, Sawka AM, Jang R, Ezzat S (2019) The Clinicopathological Spectrum of Parathyroid Carcinoma. Front Endocrinol (Lausanne) 10:731. https://doi.org/10.3389/fendo.2019.00731.

Roser P, Leca BM, Coelho C, Schulte KM, Gilbert J, Drakou EE, Kosmas C, Chuah LL, Wassati H, Miras AD, Crane J, Aylwin SJB, Grossman AB, Dimitriadis GK (2023) Diagnosis and management of parathyroid carcinoma: a state of the art review. Endocr Relat Cancer ERC-22–0287. https://doi.org/10.1530/ERC-22-0287.

de Mestier L, Hentic O, Cros J, Walter T, Roquin G, Brixi H, Lombard-Bohas C, Hammel P, Diebold MD, Couvelard A, Ruszniewski P, Cadiot G (2015) Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study. Ann Intern Med 162:682–689. https://doi.org/10.7326/M14-2132.

Crona J, Norlén O, Antonodimitrakis P, Welin S, Stålberg P, Eriksson B (2016) Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours. J Clin Endocrinol Metab 101:445–452. https://doi.org/10.1210/jc.2015-2436.

Kamp K, Alwani RA, Korpershoek E, Franssen GJ, de Herder WW, Feelders RA (2016) Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur J Endocrinol 174:271–280. https://doi.org/10.1530/EJE-15-0968.

Kamp K, Feelders RA, van Adrichem RC, de Rijke YB, van Nederveen FH, Kwekkeboom DJ, de Herder WW (2014) Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up. J Clin Endocrinol Metab 99:3060–3069. https://doi.org/10.1210/jc.2014-1315.

Tassi V, Daddi N, Mete O (2023) Not All Multifocal Pulmonary Neuroendocrine Cell Proliferations Represent Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. Ann Thorac Surg 115:547–548. https://doi.org/10.1016/j.athoracsur.2022.05.009.

Ramirez RA, Cass AS, Das S, Low SW, Mehrad M, Rickman OB, Scherer PM, Thomas KE, Gillaspie EA (2022) A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review. Transl Lung Cancer Res 11:2567–2587. https://doi.org/10.21037/tlcr-22-415.

Tassi V, Scarnecchia E, Ferolla P, Mete O, Manjula M, Allison F, Potenza R, Vannucci J, Ceccarelli S, Yasufuku K, De Perrot M, Pierre A, Darling G, Colella R, Ascani S, Mattioli S, Keshavjee S, Waddell TK, Puma F, Daddi N (2022) Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid. Ann Thorac Surg 113:966–974. https://doi.org/10.1016/j.athoracsur.2021.03.069.

Hayes AR, Luong TV, Banks J, Shah H, Watkins J, Lim E, Patel A, Grossman AB, Navalkissoor S, Krell D, Caplin ME (2022) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours. J Neuroendocrinol 34:e13184. https://doi.org/10.1111/jne.13184.

Asa SL, Ezzat S, Mete O (2018) The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med 7:280. https://doi.org/10.3390/jcm7090280.

van Adrichem RC, Kamp K, van Deurzen CH, Biermann K, Feelders RA, Franssen GJ, Kwekkeboom DJ, Hofland LJ, de Herder WW (2016) Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response? Neuroendocrinology 103:560–566. https://doi.org/10.1159/000441604.

Norlén O, Montan H, Hellman P, Stålberg P, Sundin A (2018) Preoperative 68Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions. World J Surg 42:498–505. https://doi.org/10.1007/s00268-017-4364-1.

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J (2021) Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer 146:56–73. https://doi.org/10.1016/j.ejca.2021.01.008.

Falco EC, Daniele L, Metovic J, Bollito E, De Rosa G, Volante M, Papotti M (2021) Adrenal Rests in the Uro-genital Tract of an Adult Population. Endocr Pathol 32:375–384. https://doi.org/10.1007/s12022-021-09685-y.

Nakamura Y, Maekawa T, Felizola SJ, Satoh F, Qi X, Velarde-Miranda C, Plonczynski MW, Ise K, Kikuchi K, Rainey WE, Gomez-Sanchez EP, Gomez-Sanchez CE, Sasano H (2014) Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol 392:73–79. https://doi.org/10.1016/j.mce.2014.05.002.

Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, Berruti A, Terzolo M, Fassina A, Volante M, Papotti M (2017) Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma. Hum Pathol 62:1–7. https://doi.org/10.1016/j.humpath.2016.09.035.

Opalińska M, Sowa-Staszczak A, Olearska H, Ulatowska-Bialas M, Gilis-Januszewska A, Hubalewska-Dydejczyk A (2021) Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma. Front Endocrinol (Lausanne) 12:770266. https://doi.org/10.3389/fendo.2021.770266.

Hodgson A, Pakbaz S, Shenouda C, Francis JA, Mete O (2020) Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers. Endocr Pathol 31:315–319. https://doi.org/10.1007/s12022-020-09639-w.

Janszen EW, van Doorn HC, Ewing PC, de Krijger RR, de Wilt JH, Kam BL, de Herder WW (2008) Malignant struma ovarii: good response after thyroidectomy and I ablation therapy. Clin Med Oncol 2:147–152. https://doi.org/10.4137/cmo.s410.

Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D, Kaltsas G, Klimacek B, Knigge U, Kolasińska-Ćwikła A, Kolb W, Kos-Kudła B, Kunze CA, Landolfi S, La Rosa S, López CL, Lorenz K, Matter M, Mazal P, Mestre-Alagarda C, Del Burgo PM, van Dijkum EJMN, Oleinikov K, Orci LA, Panzuto F, Pavel M, Perrier M, Reims HM, Rindi G, Rinke A, Rinzivillo M, Sagaert X, Satiroglu I, Selberherr A, Siebenhüner AR, Tesselaar MET, Thalhammer MJ, Thiis-Evensen E, Toumpanakis C, Vandamme T, van den Berg JG, Vanoli A, van Velthuysen MF, Verslype C, Vorburger SA, Lugli A, Ramage J, Zwahlen M, Perren A, Kaderli RM (2023) Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study. Lancet Oncol 24:187–194. https://doi.org/10.1016/S1470-2045(22)00750-1.

Toumpanakis C, Fazio N, Tiensuu Janson E, Hörsch D, Pascher A, Reed N, O Apos Toole D, Nieveen van Dijkum E, Partelli S, Rinke A, Kos-Kudla B, Costa F, Pape UF, Grozinsky-Glasberg S, Scoazec JY; The ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants (2019) Unmet Needs in Appendiceal Neuroendocrine Neoplasms. Neuroendocrinology 108:37–44. https://doi.org/10.1159/000493894.

Pape UF, Niederle B, Costa F, Gross D, Kelestimur F, Kianmanesh R, Knigge U, Öberg K, Pavel M, Perren A, Toumpanakis C, O'Connor J, Krenning E, Reed N, O'Toole D; Vienna Consensus Conference participants (2016) ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas). Neuroendocrinology 103:144–52. https://doi.org/10.1159/000443165.

Armeni E, Grossman A (2023) The Spectrum of Familial Pituitary Neuroendocrine Tumors. Endocr Pathol 34:57–78. https://doi.org/10.1007/s12022-022-09742-0.

Asa SL, Ezzat S (2021) An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism. J Clin Med 10:2254. https://doi.org/10.3390/jcm10112254.

Dénes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L, Kumar A, Wassif C, Fersht N, Baldeweg SE, Morris D, Lightman S, Agha A, Rees A, Grieve J, Powell M, Boguszewski CL, Dutta P, Thakker RV, Srirangalingam U, Thompson CJ, Druce M, Higham C, Davis J, Eeles R, Stevenson M, O'Sullivan B, Taniere P, Skordilis K, Gabrovska P, Barlier A, Webb SM, Aulinas A, Drake WM, Bevan JS, Preda C, Dalantaeva N, Ribeiro-Oliveira A Jr, Garcia IT, Yordanova G, Iotova V, Evanson J, Grossman AB, Trouillas J, Ellard S, Stratakis CA, Maher ER, Roncaroli F, Korbonits M (2015) Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100:E531–541. https://doi.org/10.1210/jc.2014-3399.

Nosé V, Gill A, Teijeiro JMC, Perren A, Erickson L (2022) Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. Endocr Pathol 33:197–227. https://doi.org/10.1007/s12022-022-09705-5.

Larouche V, Akirov A, Thomas CM, Krzyzanowska MK, Ezzat S (2019) A primer on the genetics of medullary thyroid cancer. Curr Oncol 26:389–394. https://doi.org/10.3747/co.26.5553.

Xu B, Fuchs TL, Ahmadi S, Alghamdi M, Alzumaili B, Bani MA, Baudin E, Chou A, De Leo A, Fagin JA, Ganly I, Glover A, Hartl D, Kanaan C, Khneisser P, Najdawi F, Nigam A, Papachristos A, Repaci A, Spanheimer PM, Solaroli E, Untch BR, Barletta JA, Tallini G, Al Ghuzlan A, Gill AJ, Ghossein RA (2022) International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. J Clin Oncol 40:96–104. https://doi.org/10.1200/JCO.21.01329.

Mete O, Tischler AS, de Krijger R, McNicol AM, Eisenhofer G, Pacak K, Ezzat S, Asa SL (2014) Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. Arch Pathol Lab Med 138:182–188. https://doi.org/10.5858/arpa.2012-0551-OA.

Mete O, Asa SL (2013) Precursor lesions of endocrine system neoplasms. Pathology 45:316–30. https://doi.org/10.1097/PAT.0b013e32835f45c5.

La Rosa S, Sessa F, Uccella S (2016) Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms. Endocr Pathol 27:284–311. https://doi.org/10.1007/s12022-016-9432-9.

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL (2022) Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 33:115–154. https://doi.org/10.1007/s12022-022-09708-2.

La Rosa S (2021) Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms. Endocr Pathol 32:245–257. https://doi.org/10.1007/s12022-021-09676-z.

Mohamed A, Hassan MM, Zhong W, Kousar A, Takeda K, Donthi D, Rizvi A, Majeed M, Younes AI, Ali A, Sutton A, Murray G, Thayyil A, Fallon J, Geisinger K (2022) A Quantitative and Qualitative Assessment of Frozen Section Diagnosis Accuracy and Deferral Rate Across Organ Systems. Am J Clin Pathol 158:692–701. https://doi.org/10.1093/ajcp/aqac115.

Ye Q, Woo JS, Zhao Q, Wang P, Huang P, Chen L, Li X, Xu K, Yong Y, Sung-Eun Yang S, Rao J (2017) Fine-Needle Aspiration Versus Frozen Section in the Evaluation of Malignant Thyroid Nodules in Patients With the Diagnosis of Suspicious for Malignancy or Malignancy by Fine-Needle Aspiration. Arch Pathol Lab Med 141:684–689. https://doi.org/10.5858/arpa.2016-0305-OA.

Du W, Fang Q, Dai L, Fan J (2022) Fine-needle aspiration biopsy versus frozen section examination in assessing cervical lymph node metastasis in primary clinically positive neck papillary thyroid carcinoma. Diagn Cytopathol 50:217–222. https://doi.org/10.1002/dc.24935.

Fawcett C, Eppenberger-Castori S, Zechmann S, Hanke J, Herzog M, Savic Prince S, Christ ER, Ebrahimi F (2022) Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration. Acta Cytol 66:371–378. https://doi.org/10.1159/000522662.

Muri R, Trippel M, Borner U, Weidner S, Trepp R (2022) The Impact of Rapid On-Site Evaluation on the Quality and Diagnostic Value of Thyroid Nodule Fine-Needle Aspirations. Thyroid 32:667–674. https://doi.org/10.1089/thy.2021.0551.

Pastorello RG, Destefani C, Pinto PH, Credidio CH, Reis RX, Rodrigues TA, Toledo MC, De Brot L, Costa FA, do Nascimento AG, Pinto CAL, Saieg MA (2018) The impact of rapid on-site evaluation on thyroid fine-needle aspiration biopsy: A 2-year cancer center institutional experience. Cancer Cytopathol 126:846–852. https://doi.org/10.1002/cncy.22051.

Aydin H, Dural AC, Sahbaz NA, Karli M, Guzey D, Akarsu C, Ferahman S, Piskinpasa H, Yegul D, Sipahi M, Koyuncu A, Altinay S, Karabulut M (2021) Clinical adaptation of auxiliary methods and multidisciplinary approach to changing trends in parathyroid surgery. Medicine (Baltimore) 100:e27160. https://doi.org/10.1097/MD.0000000000027160.

Qiao N, Swearingen B, Hedley-Whyte ET, Tritos NA (2019) The Utility of Intraoperative Cytological Smear and Frozen Section in the Surgical Management of Patients with Cushing's Disease due to Pituitary Microadenomas. Endocr Pathol 30:180–188. https://doi.org/10.1007/s12022-019-09582-5.

Mehmood S, Jahan A, Loya A, Yusuf MA (2015) Onsite cytopathology evaluation and ancillary studies beneficial in EUS-FNA of pancreatic, mediastinal, intra-abdominal, and submucosal lesions. Diagn Cytopathol 43:278–286. https://doi.org/10.1002/dc.23207.

Couvelard A, Sauvanet A (2008) Gastroenteropancreatic neuroendocrine tumors: indications for and pitfalls of frozen section examination. Virchows Arch 453:441–448. https://doi.org/10.1007/s00428-008-0678-6.

Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M (2018) Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. Expert Rev Anticancer Ther 18:1125–1133. https://doi.org/10.1080/14737140.2018.1510325.

Volynskaya Z, Chow H, Evans A, Wolff A, Lagmay-Traya C, Asa SL (2018) Integrated Pathology Informatics Enables High-Quality Personalized and Precision Medicine: Digital Pathology and Beyond. Arch Pathol Lab Med 142:369–382. https://doi.org/10.5858/arpa.2017-0139-OA.

Thomasian NM, Kamel IR, Bai HX (2022) Machine intelligence in non-invasive endocrine cancer diagnostics. Nat Rev Endocrino 18:81–95. https://doi.org/10.1038/s41574-021-00543-9.

Yu YY, Zhu ZG (2010) Significance of biological resource collection and tumor tissue bank creation. World J Gastrointest Oncol 2:5–8. https://doi.org/10.4251/wjgo.v2.i1.5.

Ladd AC, O'Sullivan-Mejia E, Lea T, Perry J, Dumur CI, Dragoescu E, Garrett CT, Powers CN (2011) Preservation of fine-needle aspiration specimens for future use in RNA-based molecular testing. Cancer Cytopathol 119:102–110. https://doi.org/10.1002/cncy.20130.

Thomas GA, Bethel JA, Galpine A, Mathieson W, Krznaric M, Unger K (2011) Integrating research on thyroid cancer after Chernobyl--the Chernobyl Tissue Bank. Clin Oncol (R Coll Radiol) 23:276–281. https://doi.org/10.1016/j.clon.2011.01.503.

Lassalle S, Hofman V, Ilie M, Butori C, Bonnetaud C, Gaziello MC, Selva E, Gavric-Tanga V, Guevara N, Castillo L, Santini J, Chabannon C, Hofman P (2011) Setting up a Prospective Thyroid Biobank for Translational Research: Practical Approach of a Single Institution (2004–2009, Pasteur Hospital, Nice, France). Biopreserv Biobank 9:9–19. https://doi.org/10.1089/bio.2010.0024.

Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690. https://doi.org/10.1016/j.cell.2014.09.050.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network; Hammer GD, Giordano TJ, Verhaak RGW (2016) Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell 29:723–736. https://doi.org/10.1016/j.ccell.2016.04.002.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network; Pacak K, Nathanson KL, Wilkerson MD (2017) Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31:181–193. https://doi.org/10.1016/j.ccell.2017.01.001.

Nohle DG, Mandt RL, Couce ME, Parwani AV, Ayers LW (2018) Acceptable Weight Ranges for Research Tissue Procurement and Biorepositories, 2015–2017. Biopreserv Biobank 16:463–466. https://doi.org/10.1089/bio.2018.0068.

van Koetsveld PM, Creemers SG, Dogan F, Franssen GJH, de Herder WW, Feelders RA, Hofland LJ (2020) The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures. J Clin Endocrinol Metab 105:407–417. https://doi.org/10.1210/clinem/dgz001.

Dijkstra KK, van den Berg JG, Weeber F, van de Haar J, Velds A, Kaing S, Peters DDGC, Eskens FALM, de Groot DA, Tesselaar MET, Voest EE (2021) Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma. Front Endocrinol (Lausanne) 12:627819. https://doi.org/10.3389/fendo.2021.627819.

Kawasaki K, Toshimitsu K, Matano M, Fujita M, Fujii M, Togasaki K, Ebisudani T, Shimokawa M, Takano A, Takahashi S, Ohta Y, Nanki K, Igarashi R, Ishimaru K, Ishida H, Sukawa Y, Sugimoto S, Saito Y, Maejima K, Sasagawa S, Lee H, Kim HG, Ha K, Hamamoto J, Fukunaga K, Maekawa A, Tanabe M, Ishihara S, Hamamoto Y, Yasuda H, Sekine S, Kudo A, Kitagawa Y, Kanai T, Nakagawa H, Sato T (2020) An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping. Cell 183:1420–1435.e21. https://doi.org/10.1016/j.cell.2020.10.023.

Wang K, Schütze I, Gulde S, Bechmann N, Richter S, Helm J, Lauseker M, Maurer J, Reul A, Spoettl G, Klink B, William D, Knösel T, Friemel J, Bihl M, Weber A, Fankhauser M, Schober L, Vetter D, Broglie Däppen M, Ziegler CG, Ullrich M, Pietzsch J, Bornstein SR, Lottspeich C, Kroiss M, Fassnacht M, Wenter VUJ, Ladurner R, Hantel C, Reincke M, Eisenhofer G, Grossman AB, Pacak K, Beuschlein F, Auernhammer CJ, Pellegata NS, Nölting S (2022) Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. Endocr Relat Cancer 29:285–306. https://doi.org/10.1530/ERC-21-0355.

Mathieson W, Betsou F, Myshunina T, Pushkarev V, Pushkarev V, Shinkarkina A, Voskoboynyk L, Thomas GA (2016) The effect of long-term -80°C storage of thyroid biospecimens on RNA quality and ensuring fitness for purpose. J Clin Pathol 69:1105–1108. https://doi.org/10.1136/jclinpath-2016-203697.

Bode-Lesniewska B, Cochand-Priollet B, Straccia P, Fadda G, Bongiovanni M (2019) Management of thyroid cytological material, preanalytical procedures and bio-banking. Cytopathology 30:7–16. https://doi.org/10.1111/cyt.12586.

Annaratone L, De Palma G, Bonizzi G, Sapino A, Botti G, Berrino E, Mannelli C, Arcella P, Di Martino S, Steffan A, Daidone MG, Canzonieri V, Parodi B, Paradiso AV, Barberis M, Marchiò C; Alleanza Contro il Cancro (ACC) Pathology and Biobanking Working Group (2021) Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch 479:233–246. https://doi.org/10.1007/s00428-021-03151-0.

Cheung CC, Martin BR, Asa SL (2013) Defining diagnostic tissue in the era of personalized medicine. CMAJ 185:135–9. https://doi.org/10.1503/cmaj.1205